Identification of More than One Mutation in the Hepatitis B Virus Polymerase Gene Arising during Prolonged Lamivudine Treatment

Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)

1995 • 524 citations

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1996 • 470 citations

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1997 • 456 citations

Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudinein vivo

1996 • 454 citations

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

1996 • 398 citations

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

1993 • 320 citations

Lamivudine resistance inimmunocompetent chronic hepatitis B

1997 • 276 citations

The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine

1993 • 234 citations

Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA™ with Amplicor™ reverse transcription-PCR amplification and correlation with quantitative culture

1996 • 107 citations

Genotypic and phenotypic characterization of HIV-1 isolated from patients receiving (−)-2′,3′-dideoxy-3′-thiacytidine

1995 • 84 citations

Generation of duck hepatitis B virus polymerase mutants through site-directed mutagenesis which demonstrate resistance to lamivudine [(--)-beta-L-2', 3'-dideoxy-3'-thiacytidine] in vitro

1996 • 68 citations

New nucleoside analogues for chronic hepatitis B.

1995 • 55 citations

Cited By (0)

Loading...